Potential long-term toxicities should influence the choice of therapy for indolent non-Hodgkin's lymphoma
Related Experiment Video
Updated: Jul 19, 2026

10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Haematologica
|November 4, 2006
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Comorbidity Burden and Prognosis in Patients Aged 80+ Years With Large B-Cell Lymphoma.
Clinical lymphoma, myeloma & leukemia·2026
Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma.
American journal of hematology·2026
Low incidence, high stakes: BCMA CAR-T and parkinsonism.
Haematologica·2026
BCL6 in B-cell lymphomas: old target, new tricks?
Haematologica·2026
Leveraging non-concurrent controls for time-to-event endpoints in platform trials for infectious diseases.
Journal of biopharmaceutical statistics·2026
C5aR1 and C5aR2 deficiency confer different degrees of protection against imiquimod-induced psoriasiform dermatitis.
Clinical and experimental immunology·2026
An Observational Study of Programmed Cell Death In Hypertrophic Scars and Keloids Based on Bibliometric Analysis.
The Journal of craniofacial surgery·2026